UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Experience of switching from a daily to a less frequent administration of injection treatments

PloS one, 2022-11, Vol.17 (11), p.e0278293-e0278293

2022

Volltextzugriff (PDF)

Targeted literature review of the humanistic and economic burden of adult growth hormone deficiency

Current medical research and opinion, 2019-06, Vol.35 (6), p.963-973

2019

Volltextzugriff (PDF)

A Phase 2/3, Multicenter, Randomized, Double-Masked, 2-Year Trial of Pegaptanib Sodium for the Treatment of Diabetic Macular Edema

Ophthalmology (Rochester, Minn.), 2011-06, Vol.118 (6), p.1107-1118

2011

Volltextzugriff (PDF)

Characterizing the High Disease Burden of Transthyretin Amyloidosis for Patients and Caregivers

Neurology and therapy, 2018-12, Vol.7 (2), p.349-364

2018

Volltextzugriff (PDF)

Factors Driving Patient Preferences for Growth Hormone Deficiency (GHD) Injection Regimen and Injection Device Features: A Discrete Choice Experiment

Patient preference and adherence, 2020-01, Vol.14, p.781-793

2020

Volltextzugriff (PDF)

Physician experience with once-weekly somatrogon versus once-daily rhGH regimen in pediatric patients with growth hormone deficiency: a cross-sectional survey of physicians from the global phase 3 study

Frontiers in endocrinology (Lausanne), 2023-10, Vol.14, p.1254424-1254424

2023

Volltextzugriff (PDF)

Changes in vision- and health-related quality of life in patients with diabetic macular edema treated with pegaptanib sodium or sham

Investigative ophthalmology & visual science, 2011-09, Vol.52 (10), p.7498-7505

2011

Volltextzugriff (PDF)

Persistence with daily growth hormone among children and adolescents with growth hormone deficiency in the UK

Frontiers in endocrinology (Lausanne), 2022-11, Vol.13, p.1014743-1014743

2022

Volltextzugriff (PDF)

Understanding patient and caregiver perspectives using a dyad approach for data collection: A systematic review of the literature

Patient experience journal, 2022-08, Vol.9 (2), p.71-81

2022

Volltextzugriff (PDF)

Health-related quality of life in pre-pubertal children with pediatric growth hormone deficiency: 12-month results from a phase 3 clinical trial of once-weekly somatrogon versus once-daily somatropin

Current medical research and opinion, 2024-02, Vol.40 (2), p.175-184

2024

Volltextzugriff (PDF)

The cost-effectiveness of growth hormone replacement therapy (Genotropin®) in hypopituitary adults in Sweden

Cost effectiveness and resource allocation, 2013-09, Vol.11 (1), p.24-24

2013

Volltextzugriff (PDF)

Cost-effectiveness and cost-utility analysis of somatrogon once-weekly injections vs. daily growth hormone injection for treating paediatric growth hormone deficiency in Ireland

Journal of medical economics, 2023, Vol.26 (1), p.963-972

2023

Volltextzugriff (PDF)

Impact of Daily Growth Hormone Adherence on Height Velocity Among Children With Growth Hormone Deficiency (GHD)

Endocrine practice, 2024-09, Vol.30 (9), p.837-846

2024

Volltextzugriff (PDF)

Suboptimal adherence to daily growth hormone in a US real-world study: an unmet need in the treatment of pediatric growth hormone deficiency

Current medical research and opinion, 2021-12, Vol.37 (12), p.2141-2150

2021

Volltextzugriff (PDF)

Association of Daily Growth Hormone Injection Adherence and Height Among Children With Growth Hormone Deficiency

Endocrine practice, 2022-06, Vol.28 (6), p.565-571

2022

Volltextzugriff (PDF)

Patient-reported outcomes in patients with acromegaly treated with pegvisomant in the ACROSTUDY extension: A real-world experience

Pituitary, 2022-06, Vol.25 (3), p.420-432

2022

Volltextzugriff (PDF)

The evolving role of patient preference studies in health-care decision-making, from clinical drug development to clinical care management

Expert review of pharmacoeconomics & outcomes research, 2019-07, Vol.19 (4), p.383-396

2019

Volltextzugriff (PDF)

Burden of illness, visual impairment and health resource utilisation of patients with neovascular age-related macular degeneration: results from the UK cohort of a five-country cross-sectional study

British journal of ophthalmology, 2007-10, Vol.91 (10), p.1303-1307

2007

Volltextzugriff (PDF)

Suboptimal adherence to prescribed daily growth hormone regimen among medicaid beneficiaries in the United States

Current medical research and opinion, 2022-06, Vol.38 (6), p.917-925

2022

Volltextzugriff (PDF)

PMON329 Survey of physician experience with once weekly somatrogon vs once daily somatropin regimen for the treatment of pediatric patients with growth hormone deficiency: results from a cross sectional, observational study

Journal of the Endocrine Society, 2022-11, Vol.6 (Supplement_1), p.A628-A629

2022

Volltextzugriff (PDF)

Long-term Medical Management of Primary Open-Angle Glaucoma and Ocular Hypertension in the UK: Optimizing Cost-Effectiveness and Clinic Resources by Minimizing Therapy Switches

Journal of glaucoma, 2012-09, Vol.21 (7), p.433-449

2012

Volltextzugriff (PDF)

Abstract #1205 A Comparison of Treatment Patterns and Switches Among Acromegaly Patients Treated with GHRA Compared with Patients Treated with SSAS

Endocrine practice, 2018-04, Vol.24, p.305-306

2018

Volltextzugriff (PDF)

Psychometric validation of the Visual Function Questionnaire-25 in patients with diabetic macular edema

Health and quality of life outcomes, 2013-01, Vol.11 (1), p.10-10

2013

Volltextzugriff (PDF)

ODP392 Persistence with daily growth hormone treatment among pediatric patients with growth hormone deficiency in the UK

Journal of the Endocrine Society, 2022-11, Vol.6 (Supplement_1), p.A605-A606

2022

Volltextzugriff (PDF)

Individualised growth response optimisation (iGRO) tool: an accessible and easy-to-use growth prediction system to enable treatment optimisation for children treated with growth hormone

Journal of Pediatric Endocrinology and Metabolism, 2017-10, Vol.30 (10), p.1019

2017

Volltextzugriff (PDF)

1 – 25 von 104

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(88)
Mit Volltextzugriff
(85)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

Englisch
(102)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Experience of switching from a daily to a less frequent administration of injection treatments

Targeted literature review of the humanistic and economic burden of adult growth hormone deficiency

A Phase 2/3, Multicenter, Randomized, Double-Masked, 2-Year Trial of Pegaptanib Sodium for the Treatment of Diabetic Macular Edema

Characterizing the High Disease Burden of Transthyretin Amyloidosis for Patients and Caregivers

Factors Driving Patient Preferences for Growth Hormone Deficiency (GHD) Injection Regimen and Injection Device Features: A Discrete Choice Experiment

Physician experience with once-weekly somatrogon versus once-daily rhGH regimen in pediatric patients with growth hormone deficiency: a cross-sectional survey of physicians from the global phase 3 study

Changes in vision- and health-related quality of life in patients with diabetic macular edema treated with pegaptanib sodium or sham

Persistence with daily growth hormone among children and adolescents with growth hormone deficiency in the UK

Understanding patient and caregiver perspectives using a dyad approach for data collection: A systematic review of the literature

Health-related quality of life in pre-pubertal children with pediatric growth hormone deficiency: 12-month results from a phase 3 clinical trial of once-weekly somatrogon versus once-daily somatropin

The cost-effectiveness of growth hormone replacement therapy (Genotropin®) in hypopituitary adults in Sweden

Cost-effectiveness and cost-utility analysis of somatrogon once-weekly injections vs. daily growth hormone injection for treating paediatric growth hormone deficiency in Ireland

Impact of Daily Growth Hormone Adherence on Height Velocity Among Children With Growth Hormone Deficiency (GHD)

Suboptimal adherence to daily growth hormone in a US real-world study: an unmet need in the treatment of pediatric growth hormone deficiency

Association of Daily Growth Hormone Injection Adherence and Height Among Children With Growth Hormone Deficiency

Patient-reported outcomes in patients with acromegaly treated with pegvisomant in the ACROSTUDY extension: A real-world experience

The evolving role of patient preference studies in health-care decision-making, from clinical drug development to clinical care management

Burden of illness, visual impairment and health resource utilisation of patients with neovascular age-related macular degeneration: results from the UK cohort of a five-country cross-sectional study

Suboptimal adherence to prescribed daily growth hormone regimen among medicaid beneficiaries in the United States

PMON329 Survey of physician experience with once weekly somatrogon vs once daily somatropin regimen for the treatment of pediatric patients with growth hormone deficiency: results from a cross sectional, observational study

Long-term Medical Management of Primary Open-Angle Glaucoma and Ocular Hypertension in the UK: Optimizing Cost-Effectiveness and Clinic Resources by Minimizing Therapy Switches

Abstract #1205 A Comparison of Treatment Patterns and Switches Among Acromegaly Patients Treated with GHRA Compared with Patients Treated with SSAS

Psychometric validation of the Visual Function Questionnaire-25 in patients with diabetic macular edema

ODP392 Persistence with daily growth hormone treatment among pediatric patients with growth hormone deficiency in the UK

Individualised growth response optimisation (iGRO) tool: an accessible and easy-to-use growth prediction system to enable treatment optimisation for children treated with growth hormone

Suchergebnisse filtern